Brief: AstraZeneca Says Truqap Approved In US For Prostate Cancer
15/06/2026 07:32
BRIEF-AstraZeneca Says Truqap Approved In US For Prostate Cancer June 15 (Reuters) - AstraZeneca PLC AZN.L:
ASTRAZENECA PLC - TRUQAP APPROVED IN US FOR PROSTATE CANCER
ASTRAZENECA PLC - TRUQAP APPROVED IN US FOR PROSTATE CANCER
ASTRAZENECA - FDA APPROVES TRUQAP COMBINATION AS FIRST TARGETED TREATMENT FOR PTEN-DEFICIENT METASTATIC PROSTATE CANCER
Source text: ID:nRSO1983Ia
Further company coverage: AZN.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AstraZeneca
See all newsUS military requires flu vaccine for some after outbreak in Texas training center
Nuvectis gains two experimental drugs in licensing deal with China's Haisco (updated)
Nuvectis gains two experimental drugs in licensing deal with China's Haisco
Press Digest: British Business - June 22
Moderna's mRNA flu vaccine backed by FDA advisers (updated)